Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated November 3, 2025, reports a transaction in the company's own shares. The filing covers share repurchase activities executed on October 31, 2025, as part of an existing buyback programme.
Key Financial Metrics and Transaction Details
The filing details a specific block of share purchases rather than operational financial results (revenue, profit, or cash flow). Key metrics for the reported transaction include:
- Shares Purchased: 175,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,760.00 GBp; highest price paid was 1,791.50 GBp.
- Average Price: Volume-weighted average price paid was 1,780.09 GBp.
- Programme Progress: Since September 30, 2025, the company has purchased an aggregate of 7,303,500 ordinary shares.
- Treasury Holdings: Following this purchase, GSK holds 254,768,344 ordinary shares in treasury.
- Shares in Issue: 4,060,655,255 ordinary shares (excluding treasury shares).
- Voting Rights: Treasury shares represent 6.27% of total voting rights.
Material Changes
The primary material change reported is the reduction of shares in issue and the increase in treasury stock resulting from the October 31, 2025, repurchase. The filing confirms the transaction was effected pursuant to a non-discretionary agreement with BNP Paribas SA, announced on September 30, 2025. No operational changes, debt modifications, or liquidity shifts are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, outlook, or management commentary regarding operational performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in the 2024 Annual Report on Form 20-F and Q3 2025 results. The filing does not disclose specific new contingencies or unusual items beyond the routine execution of the share buyback.
Investor Verification Checklist
- Verify the total cost of the 175,000 shares purchased against the volume-weighted average price of 1,780.09 GBp.
- Confirm the updated total number of shares in issue (4,060,655,255) for dividend and voting calculations.
- Review the remaining capacity of the buyback programme announced on September 30, 2025, to assess future capital return potential.
- Check the 6.27% treasury shareholding percentage against regulatory thresholds for disclosure obligations.